http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102552285-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b93c2aafeb1bcb1019daee345cc8f141 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate | 2012-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7ec48b24885c484cd758715fd734108 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed08b7fa92e6e4b133f42549c4e71100 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcedc3b033987687257723f764bb0942 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ebf7fd0f2cc56482bbd981d98b719bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49c59b06d29f3a00777bc2737a0b9757 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_805761a16acdfc5dd692b0be8188b09e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_322d0930e5a3dfa67d0da0c3f19d2c52 |
| publicationDate | 2013-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102552285-B |
| titleOfInvention | Application of schizandronic acid in preparation of medicines for preventing and treating hepatitis virus |
| abstract | The invention provides application of schizandronic acid to the preparation of medicines for preventing and treating hepatitis virus. The schizandronic acid is a tetracyclic triterpenoid compound. The invention also provides application of schizandronic acid to the preparation of food and health-care products for protecting liver. The invention has the advantages that: the application of the schizandronic acid to the preparation of medicines for resisting hepatitis B virus (HBV) and hepatitis C virus (HCV) is provided for the schizandronic acid serving as the tetracyclic triterpenoid compound. Experiments results discover that the tetracyclic triterpenoid compound has the obvious activity of resisting HBV and HCV, particularly can inhibit the HCV from invading target cells, and can be used for preparing the medicines for resisting the hepatitis B virus and the hepatitis C virus. The invention provides a new source for seeking the medicines for resisting the hepatitis B virus and the hepatitis C virus. |
| priorityDate | 2012-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 89.